ProPhase Labs
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ProPhase Labs and buy or sell other stocks, ETFs, and their options commission-free!About PRPH
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment.
CEOTed William Karkus
CEOTed William Karkus
Employees96
Employees96
HeadquartersGarden City, New York
HeadquartersGarden City, New York
Founded1989
Founded1989
Employees96
Employees96
PRPH Key Statistics
Market cap16.74M
Market cap16.74M
Price-Earnings ratio-0.60
Price-Earnings ratio-0.60
Dividend yield—
Dividend yield—
Average volume37.90M
Average volume37.90M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.9349
52 Week high$0.9349
52 Week low$0.0811
52 Week low$0.0811
Stock Snapshot
With a market cap of 16.74M, ProPhase Labs(PRPH) trades at $0.36. The stock has a price-to-earnings ratio of -0.60.
On 2026-01-09, ProPhase Labs(PRPH) stock opened at —, reached a high of —, and a low of —.
ProPhase Labs(PRPH) shares are trading with a volume of 0, against a daily average of 37.9M.
During the past year, ProPhase Labs(PRPH) stock moved between $0.08 at its lowest and $0.93 at its peak.
During the past year, ProPhase Labs(PRPH) stock moved between $0.08 at its lowest and $0.93 at its peak.
People also own
Based on the portfolios of people who own PRPH. This list is generated using Robinhood data, and it’s not a recommendation.